1. Home
  2. GTN vs SPRY Comparison

GTN vs SPRY Comparison

Compare GTN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GTN

Gray Television Inc.

HOLD

Current Price

$4.61

Market Cap

432.5M

Sector

Industrials

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$4.44

Market Cap

473.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTN
SPRY
Founded
1897
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.5M
473.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GTN
SPRY
Price
$4.61
$4.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.50
$40.00
AVG Volume (30 Days)
804.3K
1.3M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
5.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,095,000,000.00
$84,278,000.00
Revenue This Year
$13.89
$87.40
Revenue Next Year
N/A
$81.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$4.07
52 Week High
$6.44
$13.15

Technical Indicators

Market Signals
Indicator
GTN
SPRY
Relative Strength Index (RSI) 46.75 36.03
Support Level $4.21 N/A
Resistance Level $4.70 $8.61
Average True Range (ATR) 0.19 0.25
MACD -0.05 -0.06
Stochastic Oscillator 28.26 22.80

Price Performance

Historical Comparison
GTN
SPRY

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: